Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease

Introduction. Previous studies have demonstrated the safety and efficacy of using Paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in patients on dialysis. The aim of the current meta-analysis was to assess the safety and efficacy of Paricalcitol for the management of SHPT in p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Han, Tianzhao, Rong, Gong, Quan, Dayong, Shu, Ying, Liang, Zhu, She, Ninglan, Liu, Manli, Yang, Bing, Cheng, Gong, Lv, Yongman, Stern, Leonard
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3591146/
https://ncbi.nlm.nih.gov/pubmed/23509710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/320560
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars